Sinopharm Group Co. Ltd.
1099.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$46.4B
Close$
Share Statistics
| Market cap | $46.40 Billion |
|---|---|
| Enterprise Value | $91.96 Billion |
| Dividend Yield | $0.79 (5.31%) |
| Earnings per Share | $2.29 |
| Beta | 0.46 |
| Outstanding Shares | 3,120,532,000 |
Return
| Return on Equity | 16.18% |
|---|---|
| Return on Assets | 3.41% |
| Return on Invested Capital | 23.49% |
Valuation & Multiples
| P/E Ratio | 5.63 |
|---|---|
| PEG | -212.58 |
| Price to Sales | 0.04 |
| Price to Book Ratio | 0.35 |
| Enterprise Value to Revenue | 0.08 |
| Enterprise Value to EBIT | 2.68 |
| Enterprise Value to Net Income | 6 |
| Total Debt to Enterprise | 0.95 |
| Debt to Equity | 1.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 20, 2026
EPS Estimate
$1.26
Average shareholder expectationRevenue Estimate
$329.05 B
Average shareholder expectationNext Earnings Call
Expected Date
March 19, 2027
EPS Estimate
$1.33
Average shareholder expectationRevenue Estimate
$333.50 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Sinopharm Group Co. Ltd.
90,447 employees
CEO: Wanyong Lian Sinopharm Group Co. Ltd. is a prominent player in the People's Republic of China's healthcare market, specializing in the wholesale and retail of pharmaceuticals, medical devices, and related health products. The company's business activ...